AFP and liver disorder: In addition, a large-scale multicenter study was performed with patients affected by liver diseases including HCC, chronic hepatitis B virus (HBV) or liver cirrhosis to assess whether DKK1 could serve as an alternative biomarker to alpha-fetoprotein (AFP) for HCC diagnosis [67].